Clinical Trial Update: BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of BP31510 Ubidecarenone nanosuspension for intravenous injection in solid tumors has completed, according to the update. The document does not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• BP31510 Ubidecarenone nanosuspension (USP) (Ubidecarenone)

Snippet

Sponsor: BPGbio | Conditions: Metastatic Cancer, Cancer | Phase 1 | Status: COMPLETED